Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
about
Guidelines on the use of liver biopsy in clinical practiceDetection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridizationMulticenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratoryManaging chronic hepatitis C virus infectionClinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infectionClinical guidelines on the management of hepatitis CPlasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver diseaseThe clinical virology of hepatitis C virusNormal aminotransferase concentrations in patients with antibodies to hepatitis C virusSignificance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBASeroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in ZimbabweChronic hepatitis C: the virus, its discovery and the natural history of the disease.Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up.Immunopathogenesis of hepatitis C virus in the immunosuppressed host.Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminasesThe management of chronic hepatitis C virus infection.AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infectionOutcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients.Established and emerging therapies for the treatment of viral hepatitis.Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.SASLT practice guidelines: management of hepatitis C virus infection.Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.Treatment of hepatitis C virus infection in intravenous drug users.Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.Impact of hepatitis C virus infection on healthy subjects on an Italian island.Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus.Hepatitis C: Recent advances.Immune-mediated liver damage in chronic hepatitis C.Therapeutic applications of alpha interferon for chronic viral hepatitis in pediatric patients.Hepatitis C virus serum markers and liver disease in children with leukemia.Laboratory diagnosis of hepatitis C.Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta-analysis.Hepatitis C virus, autoimmunity and rheumatic disease.Sustained virologic response following HCV eradication in two brothers with X-linked agammaglobulinaemia.Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians.The hepatitis C epidemic, shall we remain silent?Genotypic variation, clinical and histological characteristics of chronic hepatitis C detected at blood donor screening.
P2860
Q22306550-7847AC2C-E10E-4EBE-A36B-B8BF5D7DF25CQ24288990-095379FF-21A5-40AD-95BE-2DDFBA10FF14Q27469390-4F5D0973-CB2C-4C05-8BCE-2974BF9B812AQ27477721-790241B1-9D4F-4C58-92E4-D99CCB2BFBDDQ27477830-5E9A2AC1-1AFB-43A0-8F22-BDB3DCED4494Q27477946-58420EED-AB0E-40BB-8462-7FFBC64F0479Q27478411-37807E51-882C-4648-8724-4890055F03BFQ27481239-AB5141E7-73F1-4FB9-BD66-5A641BDB8270Q27486882-BB2419B3-BCB3-42A9-A7D7-22DAED0A695DQ27487871-9EF0DA03-0419-4A0A-A3F7-F88CEB7E1CA3Q27490198-4BF9A9E1-9268-46E8-ABCA-1F4689720AF7Q30431528-1177DBB1-5E5D-4CE0-A421-F4BE6004BF26Q31898205-2AC856C2-542A-4503-9074-48CAC25C4E28Q34148593-9182195B-23D4-4C79-8FFF-F46D68A3FB8BQ34408497-C6C348D0-E690-4D1F-A52B-7C392D186D31Q34408947-F3217623-AFB0-4CA1-B3FB-71CE2CFB0372Q34454310-A8096B7C-5A29-48DB-B1EA-777E9561A0A7Q34574104-F957A983-D3C3-4D69-91A7-AC61B841D71EQ34589232-12B39063-2D45-4FCA-A2B0-0C07B9A9E407Q35596078-4201C0C1-F247-469D-B881-11E1DF79DB9FQ36011590-288989E7-4D25-43A8-AB75-DFD13FFA4E86Q36478120-3F96EB1D-6844-46DF-8218-D5E3F44ADD76Q36609890-BA73C460-8EB1-467A-A7B4-10542D70947CQ37019765-CF7CD9AF-9E5D-4FF6-A8E5-8B9EC88E9ED5Q37358617-212DE749-0EBC-4CF8-9AB4-C589A253DE03Q38779490-6D69DB2B-9C76-4A04-A98B-690EEC8513F0Q39051404-E62B63C1-45D7-4495-8549-BC43AFAD19C3Q39534096-E5B501CF-6085-406B-848E-BDB89C1F6888Q39628327-42B688CB-99AA-4936-9E19-8F10FADB1F6CQ40142234-2DC24EE8-1D7B-4667-B076-38B74177444FQ40371427-C76E1BD1-8AD3-4A63-9708-0F233086B070Q40411325-8A29E923-E9F2-430F-BCAF-A1460F511B76Q40958092-4BDE7E43-93D5-4A60-A6C5-7EBE2F8D3EB7Q41351271-68C94842-90B6-4F76-9450-B5925F979FE5Q41533775-4DF3B13E-776F-47A5-A5B2-771F4E49395AQ41669589-3F809B45-0C67-4B26-8449-EF1BFC6676D6Q41817879-325E2800-DFEE-4436-927C-8EACC610E4ADQ42182711-54AC6D82-9300-4626-8886-6E00D194C85DQ42646666-54A31CCD-70D0-492F-A485-60EDA61B7FC7Q42978125-411A8EDB-64A2-4EA0-A47F-39E30A9096FF
P2860
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@en
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@nl
type
label
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@en
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@nl
prefLabel
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@en
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@nl
P2093
P1433
P1476
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
@en
P2093
D Cavalletto
L Chemello
P Pontisso
P304
P356
10.1016/0140-6736(92)92234-7
P407
P577
1992-09-01T00:00:00Z